Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1977 Jun;32(6):929–940.

Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

H U Schorlemmer, D Bitter-Suermann, A C Allison
PMCID: PMC1445433  PMID: 328387

Abstract

A number of stimuli known to induce acid hydrolase secretion from cultured macrophages were examined for their ability to activate C3 via the alternative pathway of the complement system. Loss of haemolytically active C3 was checked in normal and C4-deficient guinea-pig serum. For comparison the interactions of cultured macrophages with other agents well known as potent activators of the alternative pathway of the complement system have been investigated. As judged by their activity in these assays, group A streptococcal cell walls, different carrageenan preparations, dental plaque and Actinomyces viscosus were all capable of initiating the alternative pathway but differed with respect to their potency and their ability to inhibit C3 turnover at high concentrations. Zymosan, some carrageenans, polyanethol sulphonate, and Corynebacterium parvum all induce the release of hydrolytic enzymes from macrophages in culture, even in the absence of serum in the medium. The release is time- and dose-dependent and is not associated with loss of the cytoplasmic enzyme lactate dehydrogenase or any other sign of cell death. The parallelism between the capacity of several agents to activate the complement system via the alternative pathway and to induce inflammatory responses in vivo and selective lysosoma enzyme secretion from cultures of macrophages is discussed.

Full text

PDF
929

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentley C., Bitter-Suermann D., Hadding U., Brade V. In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages. Eur J Immunol. 1976 Jun;6(6):393–398. doi: 10.1002/eji.1830060604. [DOI] [PubMed] [Google Scholar]
  2. Bitter-Suermann D., Hadding U., Melchert F., Wellensiek H. J. Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry. 1970 Dec;7(12):955–965. doi: 10.1016/0019-2791(70)90002-9. [DOI] [PubMed] [Google Scholar]
  3. Bitter-Suermann D., Hadding U., Schorlemmer H. U., Limbert M., Dierich M., Dukor P. Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system. J Immunol. 1975 Aug;115(2):425–430. [PubMed] [Google Scholar]
  4. Bonomo L., Tursi A., Trizio D., Gillardi U., Dammacco F. Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study. Immunology. 1970 Apr;18(4):557–563. [PMC free article] [PubMed] [Google Scholar]
  5. Brade V., Lee G. D., Nicholson A., Shin H. S., Mayer M. M. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway. J Immunol. 1973 Nov;111(5):1389–1400. [PubMed] [Google Scholar]
  6. Bragg P. D., Hough L. An investigation of the egg-white mucoproteins, ovomucoid and ovalbumin. Biochem J. 1961 Jan;78(1):11–23. doi: 10.1042/bj0780011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burger R., Hadding U., Schorlemmer H. U., Brade V., Bitter-Suermann D. Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency. Immunology. 1975 Sep;29(3):549–554. [PMC free article] [PubMed] [Google Scholar]
  8. CONCHIE J., FINDLAY J., LEVVY G. A. Mammalian glycosidases; distribution in the body. Biochem J. 1959 Feb;71(2):318–325. doi: 10.1042/bj0710318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clark I. A., Allison A. C., Cox F. E. Protection of mice against Babesia and Plasmodium with BCG. Nature. 1976 Jan 29;259(5541):309–311. doi: 10.1038/259309a0. [DOI] [PubMed] [Google Scholar]
  10. DAVIES G. E. INHIBITION OF GUINEA-PIG COMPLEMENT IN VITRO AND IN VIVO BY CARRAGEENIN. Immunology. 1963 Nov;6:561–568. [PMC free article] [PubMed] [Google Scholar]
  11. Davies P., Page R. C., Allison A. C. Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med. 1974 May 1;139(5):1262–1282. doi: 10.1084/jem.139.5.1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Di Rosa M. Biological properties of carrageenan. J Pharm Pharmacol. 1972 Feb;24(2):89–102. doi: 10.1111/j.2042-7158.1972.tb08940.x. [DOI] [PubMed] [Google Scholar]
  13. Dierich M. P., Bitter-Suermann D., König W., Hadding U., Galanos C., Rietschel E. T. Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology. 1973 Apr;24(4):721–733. [PMC free article] [PubMed] [Google Scholar]
  14. Edwards J. H., Wagner J. C., Seal R. M. Pulmonary responses to particulate materials capable of activating the alternative pathway of complement. Clin Allergy. 1976 Mar;6(2):155–164. doi: 10.1111/j.1365-2222.1976.tb01893.x. [DOI] [PubMed] [Google Scholar]
  15. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  16. Gewurz H., Mergenhagen S. E., Nowotny A., Phillips J. K. Interactions of the complement system with native and chemically modified endotoxins. J Bacteriol. 1968 Feb;95(2):397–405. doi: 10.1128/jb.95.2.397-405.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ginsburg I. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J Infect Dis. 1972 Sep;126(3):294–340. doi: 10.1093/infdis/126.3.294. [DOI] [PubMed] [Google Scholar]
  18. Goldstein I. M., Weissmann G. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol. 1974 Nov;113(5):1583–1588. [PubMed] [Google Scholar]
  19. Guggenheim B., Schroeder H. E. Reactions in the periodontium to continuous antigenic stimulation in sensitized gnotobiotic rats. Infect Immun. 1974 Sep;10(3):565–577. doi: 10.1128/iai.10.3.565-577.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hadding U., Dierich M., König W., Limbert M., Schorlemmer H. U., Bitter-Suermann D. Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Eur J Immunol. 1973 Aug;3(8):527–529. doi: 10.1002/eji.1830030817. [DOI] [PubMed] [Google Scholar]
  21. Hay F. C., Torrigiani G., Roitt I. M. The binding of human IgG subclasses to human monocytes. Eur J Immunol. 1972 Jun;2(3):257–261. doi: 10.1002/eji.1830020312. [DOI] [PubMed] [Google Scholar]
  22. Juy D., Chedid L. Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants. Proc Natl Acad Sci U S A. 1975 Oct;72(10):4105–4109. doi: 10.1073/pnas.72.10.4105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kirchner H., Holden H. T., Herberman R. B. Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice. J Natl Cancer Inst. 1975 Oct;55(4):971–975. doi: 10.1093/jnci/55.4.971. [DOI] [PubMed] [Google Scholar]
  24. König W., Bitter-Suermann D., Dierich M., Hadding U. Bypass-activation of the complement system starting with C3. II. C3-activation by gamma-1-immune aggregates in guinea pig serum. Immunochemistry. 1973 Jul;10(7):431–437. doi: 10.1016/0019-2791(73)90012-8. [DOI] [PubMed] [Google Scholar]
  25. Lai A Fat R. F., van Furth R. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology. 1975 Feb;28(2):359–368. [PMC free article] [PubMed] [Google Scholar]
  26. McBride W. H., Weir D. M., Kay A. B., Pearce D., Caldwell J. R. Activation of the classical and alternate pathways of complement by Corynebacterium parvum. Clin Exp Immunol. 1975 Jan;19(1):143–147. [PMC free article] [PubMed] [Google Scholar]
  27. Ohanian S. H., Schwab J. H., Cromartie W. J. Relation of rheumatic-like cardiac lesions of the mouse to localization of group A streptococcal cell walls. J Exp Med. 1969 Jan 1;129(1):37–49. doi: 10.1084/jem.129.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Osler A. G., Oliveira B., Shin H. S., Sandberg A. L. The fixation of guinea pig complement by gamma 1 and gamma 2 immunoglobulins. J Immunol. 1969 Jan;102(1):269–271. [PubMed] [Google Scholar]
  29. PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
  30. Page R. C., Davies P., Allison A. C. Effects of dental plaque on the production and release of lysosomal hydrolases by macrophages in culture. Arch Oral Biol. 1973 Dec;18(12):1481–1495. doi: 10.1016/0003-9969(73)90124-6. [DOI] [PubMed] [Google Scholar]
  31. Page R. C., Davies P., Allison A. C. Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest. 1974 May;30(5):568–581. [PubMed] [Google Scholar]
  32. Pincus T., Haberkern R., Christian C. L. Experimental chronic glomerulitis. J Exp Med. 1968 Apr 1;127(4):819–832. doi: 10.1084/jem.127.4.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schorlemmer H. U., Allison A. C. Effects of activated complement components on enzyme secretion by macrophages. Immunology. 1976 Nov;31(5):781–788. [PMC free article] [PubMed] [Google Scholar]
  34. Spector W. G., Heesom N. The production of granulomata by antigen-antibody complexes. J Pathol. 1969 May;98(1):31–39. doi: 10.1002/path.1710980105. [DOI] [PubMed] [Google Scholar]
  35. Tauber J. W., Polley M. J., Zabriskie J. B. Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway. J Exp Med. 1976 Jun 1;143(6):1352–1366. doi: 10.1084/jem.143.6.1352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. WENZEL F., EMANUEL D. A., LAWTON B. R., MAGNIN G. E. ISOLATION OF THE CAUSATIVE AGENT OF FARMER'S LUNG. Ann Allergy. 1964 Oct;22:533–540. [PubMed] [Google Scholar]
  37. Wahl L. M., Wahl S. M., Mergenhagen S. E., Martin G. R. Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3598–3601. doi: 10.1073/pnas.71.9.3598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Warren K. S. The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg. 1972;66(3):417–434. doi: 10.1016/0035-9203(72)90273-8. [DOI] [PubMed] [Google Scholar]
  39. Weissmann G., Dukor P., Zurier R. B. Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol. 1971 Jun 2;231(22):131–135. doi: 10.1038/newbio231131a0. [DOI] [PubMed] [Google Scholar]
  40. Ziff M. Pathophysiology of rheumatoid arthritis. Fed Proc. 1973 Feb;32(2):131–133. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES